These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 17050535)
1. Recognition and blocking of HIV-1 gp41 pre-transmembrane sequence by monoclonal 4E10 antibody in a Raft-like membrane environment. Lorizate M; Cruz A; Huarte N; Kunert R; Pérez-Gil J; Nieva JL J Biol Chem; 2006 Dec; 281(51):39598-606. PubMed ID: 17050535 [TBL] [Abstract][Full Text] [Related]
2. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5. Huarte N; Lorizate M; Maeso R; Kunert R; Arranz R; Valpuesta JM; Nieva JL J Virol; 2008 Sep; 82(18):8986-96. PubMed ID: 18596094 [TBL] [Abstract][Full Text] [Related]
3. Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41. Apellániz B; Nir S; Nieva JL Biochemistry; 2009 Jun; 48(23):5320-31. PubMed ID: 19449801 [TBL] [Abstract][Full Text] [Related]
4. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems. Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693 [TBL] [Abstract][Full Text] [Related]
5. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10. Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169 [TBL] [Abstract][Full Text] [Related]
7. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies. Huarte N; Lorizate M; Kunert R; Nieva JL FEBS Lett; 2008 Nov; 582(27):3798-804. PubMed ID: 18930052 [TBL] [Abstract][Full Text] [Related]
8. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000 [TBL] [Abstract][Full Text] [Related]
9. A new paradigm in molecular recognition? Specific antibody binding to membrane-inserted HIV-1 epitopes. Nieva JL; Apellaniz B; Huarte N; Lorizate M J Mol Recognit; 2011; 24(4):642-6. PubMed ID: 21584875 [TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. Brunel FM; Zwick MB; Cardoso RM; Nelson JD; Wilson IA; Burton DR; Dawson PE J Virol; 2006 Feb; 80(4):1680-7. PubMed ID: 16439525 [TBL] [Abstract][Full Text] [Related]
11. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site. Julien JP; Bryson S; Nieva JL; Pai EF J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005 [TBL] [Abstract][Full Text] [Related]
12. Fusion-competent state induced by a C-terminal HIV-1 fusion peptide in cholesterol-rich membranes. Apellániz B; Nieva JL Biochim Biophys Acta; 2015 Apr; 1848(4):1014-22. PubMed ID: 25617671 [TBL] [Abstract][Full Text] [Related]
13. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352 [TBL] [Abstract][Full Text] [Related]
14. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272 [TBL] [Abstract][Full Text] [Related]
15. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805 [TBL] [Abstract][Full Text] [Related]
17. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization. Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698 [TBL] [Abstract][Full Text] [Related]
18. Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane. Rujas E; Insausti S; García-Porras M; Sánchez-Eugenia R; Tsumoto K; Nieva JL; Caaveiro JM J Mol Biol; 2017 Apr; 429(8):1213-1226. PubMed ID: 28300601 [TBL] [Abstract][Full Text] [Related]
19. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion. Finnegan CM; Berg W; Lewis GK; DeVico AL J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953 [TBL] [Abstract][Full Text] [Related]
20. Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies. Sánchez-Martínez S; Lorizate M; Katinger H; Kunert R; Nieva JL AIDS Res Hum Retroviruses; 2006 Oct; 22(10):998-1006. PubMed ID: 17067270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]